339 related articles for article (PubMed ID: 30607903)
1. Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation.
Crunfli F; Vrechi TA; Costa AP; Torrão AS
Neurotox Res; 2019 Apr; 35(3):516-529. PubMed ID: 30607903
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling.
Vrechi TA; Crunfli F; Costa AP; Torrão AS
Neurotox Res; 2018 May; 33(4):846-855. PubMed ID: 29134561
[TBL] [Abstract][Full Text] [Related]
3. CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AβPP/PS1 mice.
Aso E; Palomer E; Juvés S; Maldonado R; Muñoz FJ; Ferrer I
J Alzheimers Dis; 2012; 30(2):439-59. PubMed ID: 22451318
[TBL] [Abstract][Full Text] [Related]
4. The Acute Activation of the CB1 Receptor in the Hippocampus Decreases Neurotoxicity and Prevents Spatial Memory Impairment in Rats Lesioned with β-Amyloid 25-35.
Patricio-Martínez A; Sánchez-Zavaleta R; Angulo-Cruz I; Gutierrez-Praxedis L; Ramírez E; Martínez-García I; Limón ID
Neuroscience; 2019 Sep; 416():239-254. PubMed ID: 31400487
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mitochondrial permeability transition pore opening contributes to cannabinoid type 1 receptor agonist ACEA-induced neuroprotection.
Ma L; Niu W; Yang S; Tian J; Luan H; Cao M; Xi W; Tu W; Jia J; Lv J
Neuropharmacology; 2018 Jun; 135():211-222. PubMed ID: 29574098
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats.
Zhou S; Yu G; Chi L; Zhu J; Zhang W; Zhang Y; Zhang L
Neurotoxicology; 2013 Sep; 38():136-45. PubMed ID: 23932983
[TBL] [Abstract][Full Text] [Related]
7. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Kokona D; Thermos K
Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
9. Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro.
Harvey BS; Ohlsson KS; Mååg JL; Musgrave IF; Smid SD
Neurotoxicology; 2012 Jan; 33(1):138-46. PubMed ID: 22233683
[TBL] [Abstract][Full Text] [Related]
10. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
Shi L; Zhang Z; Li L; Hölscher C
Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
[TBL] [Abstract][Full Text] [Related]
11. Involvement of nitric oxide in the gastroprotective effect of ACEA, a selective cannabinoid CB1 receptor agonist, on aspirin-induced gastric ulceration.
Rutkowska M; Fereniec-Gołebiewska L
Pharmazie; 2009 Sep; 64(9):595-7. PubMed ID: 19827302
[TBL] [Abstract][Full Text] [Related]
12. [Cannabinoid receptor 1 agonist arachidonyl-2'-chloroethylamide (ACEA) improves sepsis-associated encephalopathy by inhibiting inflammatory factors].
Yang Z; Wu Y; Tang J; Liu R; Fang Z; Su B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Apr; 40(4):319-326. PubMed ID: 38710516
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D
Yamini P; Ray RS; Chopra K
Inflammopharmacology; 2018 Feb; 26(1):39-55. PubMed ID: 28702935
[TBL] [Abstract][Full Text] [Related]
15. Effects of the cannabinoid CB
Berger JI; Coomber B; Hill S; Alexander SPH; Owen W; Palmer AR; Wallace MN
Hear Res; 2017 Dec; 356():51-62. PubMed ID: 29108871
[TBL] [Abstract][Full Text] [Related]
16. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
17. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
18. Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
Andres-Mach M; Zolkowska D; Barcicka-Klosowska B; Haratym-Maj A; Florek-Luszczki M; Luszczki JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):301-9. PubMed ID: 22789660
[TBL] [Abstract][Full Text] [Related]
19. ACEA (arachidonyl-2-chloroethylamide), the selective cannabinoid CB1 receptor agonist, protects against aspirin-induced gastric ulceration.
Rutkowska M; Fereniec-Gołtbiewska L
Pharmazie; 2006 Apr; 61(4):341-2. PubMed ID: 16649551
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of 5-HT
Afshar S; Shahidi S; Rohani AH; Soleimani Asl S; Komaki A
J Chem Neuroanat; 2019 Mar; 96():140-147. PubMed ID: 30684605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
